Delving into the Latest Updates on Lundbeck Japan KK with Synapse

概览

关联

1

项与 Lundbeck Japan KK 相关的药物

Desmoteplase

去氨普酶

靶点

PLG

作用机制

PLG刺激剂

在研机构-

原研机构

Bayer AG

在研适应症-

非在研适应症

急性缺血性卒中

最高研发阶段终止

首次获批国家/地区-

首次获批日期-

4

项与 Lundbeck Japan KK 相关的临床试验

JPRN-UMIN000050370

/ CompletedN/A

Web-based patient survey on current status of goal setting and relationships between objective evaluable goal setting and patients' perceptions in treatment of depression - Web-based patient survey on current status of goal setting and relationships between objective evaluable goal setting and patients' perceptions in treatment of depression

开始日期2023-03-07

申办/合作机构

Takeda Pharmaceutical Co., Ltd.

[+1]

JPRN-UMIN000051822

/ CompletedN/A

Post hoc analysis of web-based survey (ref. UMIN000048497) on emotional blunting in Japanese patients with Major Depressive Disorder - Post hoc analysis of web-based survey (ref. UMIN000048497) on emotional blunting in Japanese patients with Major Depressive Disorder

开始日期2022-07-29

申办/合作机构

Takeda Pharmaceutical Co., Ltd.

[+1]

JPRN-UMIN000039967

/ CompletedN/A

Examination on the differences of the symptoms which should be given priority to treatment from the perspective of major depressive disorder patients vs their physicians - Examination on the differences of the symptoms which should be given priority to treatment from the perspective of major depressive disorder patients vs their physicians

开始日期2020-03-30

申办/合作机构

Takeda Pharmaceutical Co., Ltd.

[+1]

100 项与 Lundbeck Japan KK 相关的临床结果

登录后查看更多信息

0 项与 Lundbeck Japan KK 相关的专利（医药）

登录后查看更多信息

100 项与 Lundbeck Japan KK 相关的药物交易

登录后查看更多信息

100 项与 Lundbeck Japan KK 相关的转化医学

登录后查看更多信息